Guest - CEBM

OpenPrescribing – new measures now available

We’ve been spending some time at OpenPrescribing designing a set of new measures to identify interesting variations in prescribing behaviour

That school teachers receive better support from the EBM community, enabling them to take advantage of opportunities to teach EBM

Ever tried to catch a jellyfish? Or squeeze a squid in your hand? Or wrestle with an octopus? You can’t

How do you know if your product is really working for users? You can guess, you can ask them,

This guest blog was written by Dr David Warriner, a Cardiology Registrar, who has attended each Preventing Overdiagnosis conference since its

Sometimes colleagues ask me whether they should use “propensity scores” in their next study. I’m far from an expert in

The Cochrane Tobacco Addiction Group (CTAG) is one of Cochrane’s editorial groups specialising in evidence synthesis for the prevention and

Development of a Centre for Evidence-Based Medicine at Makerere University College of Health Sciences in Uganda : The role of

A few months ago, I had the opportunity to develop a programme in an Intensive Care Unit (ICU) to help

The part-time DPhil regulations normally require a minimum of six years’ part-time study (equivalent to two years’ full-time) up to

Please allow me to paraphrase a statement I read years ago: some places give you a career, but Oxford gives

Congratulations on your admission into the University of Oxford! Now what? Why do I keep receiving duplicate letters? How do

Guy Collender, Head of Alumni Communications and Marketing at the University of Oxford, reports from the Harms in Healthcare event,

My arrival at the University of Oxford has been very unexpected: all I wanted to do was to improve my

Time-dependent bias is not an issue in randomised studies as treatment (including placebo) is given at the beginning of follow